Inhibition of human platelets and polymorphonuclear neutrophils by the potent and metabolically stable prostaglandin D2 analog ZK 118.182

This publication has 25 references indexed in Scilit:

• The effects of the nitric oxide donors molsidomine and SIN-1 on human polymorphonuclear leucocyte functionin vitro andex vivo
  European Journal of Clinical Pharmacology, 1992
• Iloprost
  Drugs, 1992
• The effect of six prostaglandins, prostacyclin and iloprost on generation of superoxide anions by human polymorphonuclear leukocytes stimulated by zymosan or formyl-methionyl-leucyl-phenylalanine
  Biochemical Pharmacology, 1987
• 9 alpha,11 beta-prostaglandin F2, a novel metabolite of prostaglandin D2 is a potent contractile agonist of human and guinea pig airways.
  Journal of Clinical Investigation, 1987
• Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor
  Nature, 1986
• Inhibition of platelet-activating-factor-induced human platelet activation by prostaglandin D2. Differential sensitivity of platelet transduction processes and functional responses to inhibition by cyclic AMP
  Biochemical Journal, 1985
• Effects of intravenous infusions of prostaglandin D2 in man
  Prostaglandins, 1984
• The Bronchoconstrictor Effect of Inhaled Prostaglandin D2 in Normal and Asthmatic Men
  New England Journal of Medicine, 1984
• 9-Deoxy-Δ9-prostaglandin D2, a prostaglandin D2 derivative with potent antineoplastic and weak smooth muscle-contracting activities
  Biochemical and Biophysical Research Communications, 1982
• Aggregation of Blood Platelets by Adenosine Diphosphate and its Reversal
  Nature, 1962